Andere talen PhaseBio Pharmaceuticals, Inc.

Aandelen

PHAS.Q

US7172241090

slotkoers OTC Markets Andere beurzen 00:00:00 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,000001 ^USD	0,00%		0,00%	0,00%

07/02	Vijfde motie voor verlenging exclusiviteitsperiode goedgekeurd voor PhaseBio Pharmaceuticals, Inc.	CI
2023	Vierde motie voor verlenging exclusiviteitsperiode goedgekeurd voor PhaseBio Pharmaceuticals, Inc.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

First Amended Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc.	19/04
Fifth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.	07/02
Fourth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.	08/11
PhaseBio Pharmaceuticals, Inc. Announces Resignation of Caroline Loewy as Member of the Board of Directors	03-10-23
Third Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.	07-09-23
Modified Combined Disclosure Statement Approved on Interim Basis for PhaseBio Pharmaceuticals, Inc.	01-08-23
Second Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.	10-07-23
Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc.	07-07-23
North American Morning Briefing : Sentiment -2-	19-04-23
North American Morning Briefing : Traders Await -2-	12-04-23
North American Morning Briefing : Stock Futures -3-	05-04-23
First Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.	13-03-23
First Motion for Exclusivity Period Extension Filed by PhaseBio Pharmaceuticals, Inc.	17-02-23
Motion for Asset Sale Approved for PhaseBio Pharmaceuticals, Inc.	02-02-23
Motion for Asset Sale Approved for PhaseBio Pharmaceuticals, Inc.	02-02-23
Motion for De Minimis Assets Sale Approved for PhaseBio Pharmaceuticals, Inc.	30-01-23
Notice of Selection of Auction and Asset Purchase Agreement Filed for Filed by PhaseBio Pharmaceuticals, Inc.	20-01-23
Chiesi Farmaceutici S.p.A. cancelled the acquisition of all of the assets of PhaseBio Pharmaceuticals, Inc. primarily related to bentracimab.	19-01-23
Notice of Rescheduled Auction Filed by PhaseBio Pharmaceuticals, Inc.	13-01-23
Motion for Asset Sale Approved for PhaseBio Pharmaceuticals, Inc.	31-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PhaseBio Pharmaceuticals, Inc.

Aandelen

PHAS.Q

US7172241090

Andere talen

Filters